https://www.polity.org.za
Deepening Democracy through Access to Information
Home / Audio / Audio Articles RSS ← Back
Africa|Business|Health|Packaging|Packaging
Africa|Business|Health|Packaging|Packaging
africa|business|health|packaging-company|packaging
Close

Email this article

separate emails by commas, maximum limit of 4 addresses

Sponsored by

Close

Article Enquiry

South Africa delays Covid vaccine deliveries as it has too much stock

Close

Embed Video

South Africa delays Covid vaccine deliveries as it has too much stock

Covid-19 vaccine

24th November 2021

By: Reuters

SAVE THIS ARTICLE      EMAIL THIS ARTICLE

Font size: -+

South Africa has asked Johnson & Johnson and Pfizer to delay delivery of Covid-19 vaccines because it now has too much stock, health ministry officials said, as vaccine hesitancy slows the inoculation campaign.

About 35% of South Africans are fully vaccinated, higher than in most other African nations, but half the government's year-end target. It has averaged 106 000 doses a day in the past 15 days in a nation of 60-million people.

Advertisement

Earlier this year the programme was slowed by insufficient doses. Now deliveries have been delayed due to oversupply, making the country an outlier in the continent where most are still starved of vaccines.

Nicholas Crisp, deputy director-general of the Health Department, told Reuters that South Africa had 16.8-million doses in stock and said deliveries had been deferred.

Advertisement

"We have 158 days' stock in the country at current use," a spokesperson for the Health Ministry said. "We have deferred some deliveries."

They did not say when deliveries would now take place.

Stavros Nicolaou, chief executive of Aspen Pharmacare, which is packaging 25-million doses a month of J&J vaccines in South Africa, said most of the vaccines bound for South Africa would now go to the rest of the continent.

Nicolaou, who is also chairperson of public health at business lobby Business for South Africa (B4SA), said deliveries would likely be deferred until the first quarter of next year.

Vaccines packaged at Aspen's plant are part of the African Union's agreement to buy 220-million doses from J&J.

The AU and J&J did not respond to an email seeking comment.

A Pfizer spokesperson said: "We remain adaptable to individual country's vaccine requirements whilst continuing to meet our quarterly commitments as per the South Africa supply agreement."

South Africa's government has been seeking to boost the rate of daily administered doses.

"There is a fair amount of apathy and hesitancy," said Shabir Madhi, who led the clinical study for the AstraZeneca Covid-19 vaccine in South Africa.

To ramp up vaccinations, the government has launched pop-up vaccination centres and sought help from community leaders. It has also opened inoculations to children aged 12 to 17.

EMAIL THIS ARTICLE      SAVE THIS ARTICLE

To subscribe email subscriptions@creamermedia.co.za or click here
To advertise email advertising@creamermedia.co.za or click here

Comment Guidelines

About

Polity.org.za is a product of Creamer Media.
www.creamermedia.co.za

Other Creamer Media Products include:
Engineering News
Mining Weekly
Research Channel Africa

Read more

Subscriptions

We offer a variety of subscriptions to our Magazine, Website, PDF Reports and our photo library.

Subscriptions are available via the Creamer Media Store.

View store

Advertise

Advertising on Polity.org.za is an effective way to build and consolidate a company's profile among clients and prospective clients. Email advertising@creamermedia.co.za

View options
Free daily email newsletter Register Now